King Plans Skelaxin “Authorized” Generic When Metaxalone ANDAs Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
King will launch an "authorized" generic of Skelaxin (metaxalone) when ANDA versions of the muscle relaxant enter the marketYou may also be interested in...
Sepracor Insomnia Spot Suggests Lunesta “Product And Use” Ads Coming Soon
The unbranded spot tells patients suffering from insomnia to stay tuned for more information coming April 24 about “something on its way that could change your nights.” The ad first aired April 10. Sepracor is also planning to discuss labeling revisions with FDA based on its second six-month trial.
Skelaxin Generics May Launch Before July 2005: FDA To Allow Labeling "Carve Out"
The agency says ANDA filers Eon and Corepharma may delete protected labeling on food effects covered by King’s method-of-use patent.
Sanofi's €10bn Dupixent Plan: 'We're Going To Put The JAKs Properly In Their Place'
Sanofi's new CEO has ambitious forecasts for Dupixent in atopic dermatitis, asthma and other indications. The French pharma outlined how it plans to reach that goal despite new competition vying to get in.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: